TY - JOUR
T1 - Deferred versus conventional stent implantation in patients with acute ST-segment elevation myocardial infarction
T2 - An updated meta-analysis of 10 studies
AU - Lee, Joo Myung
AU - Rhee, Tae Min
AU - Chang, Haseong
AU - Ahn, Chul
AU - Park, Taek Kyu
AU - Yang, Jeong Hoon
AU - Song, Young Bin
AU - Choi, Seung Hyuk
AU - Gwon, Hyeon Cheol
AU - Hahn, Joo Yong
N1 - Publisher Copyright:
© 2016 Elsevier Ireland Ltd
PY - 2017/3/1
Y1 - 2017/3/1
N2 - Background We sought to evaluate safety and efficacy of the deferred stenting versus immediate stent implantation of infarct-related arteries in patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Methods A meta-analysis using random-effects models were conducted. The primary outcome, major adverse cardiac events (MACE), was a composite of all-cause mortality, myocardial infarction (MI), any unplanned target vessel revascularization (TVR), and hospitalization due to cardiac cause. Periprocedural composite events were composed of acute re-occlusion, no-reflow/slow flow, or distal embolization. Results Seven non-randomized registries and three randomized trials comparing outcomes of deferred versus immediate stenting in infarct-related arteries of 2281 STEMI patients were selected. Risk of MACE between deferred or immediate stenting did not differ significantly (rates, 12.8% vs 15.0%; pooled RR = 0.68, 95% CI: 0.43–1.06; p = 0.087; I2 = 26.8%). Deferred stenting was associated with significantly reduced risk of periprocedural composite events (rates, 5.3% vs 10.2%; pooled RR = 0.36, 95% CI: 0.18–0.69; p = 0.002; I2 = 68.0%) and flow abnormality in infarct-related arteries (rates, 3.8% vs 8.4%; pooled RR = 0.29, 95% CI: 0.14–0.61; p = 0.001; I2 = 58.1%). However, clinical outcomes including all-cause mortality, MI, or any unplanned TVR, were unaffected. Meta-regression indicated a significant relationship between prolonged total ischemic and reduced risk of MACE after deferred stenting (OR = 0.994, 95% CI: 0.990–0.998; p = 0.027; I2 residual 0.0%, adjusted R2 = 100.0%). Conclusions Although deferred stenting carried significantly lower risk of periprocedural composite events and abnormal flow in patients undergoing primary PCI for STEMI, such benefits had no impact on MACE, which did not differ significantly by timing of stent placement.
AB - Background We sought to evaluate safety and efficacy of the deferred stenting versus immediate stent implantation of infarct-related arteries in patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Methods A meta-analysis using random-effects models were conducted. The primary outcome, major adverse cardiac events (MACE), was a composite of all-cause mortality, myocardial infarction (MI), any unplanned target vessel revascularization (TVR), and hospitalization due to cardiac cause. Periprocedural composite events were composed of acute re-occlusion, no-reflow/slow flow, or distal embolization. Results Seven non-randomized registries and three randomized trials comparing outcomes of deferred versus immediate stenting in infarct-related arteries of 2281 STEMI patients were selected. Risk of MACE between deferred or immediate stenting did not differ significantly (rates, 12.8% vs 15.0%; pooled RR = 0.68, 95% CI: 0.43–1.06; p = 0.087; I2 = 26.8%). Deferred stenting was associated with significantly reduced risk of periprocedural composite events (rates, 5.3% vs 10.2%; pooled RR = 0.36, 95% CI: 0.18–0.69; p = 0.002; I2 = 68.0%) and flow abnormality in infarct-related arteries (rates, 3.8% vs 8.4%; pooled RR = 0.29, 95% CI: 0.14–0.61; p = 0.001; I2 = 58.1%). However, clinical outcomes including all-cause mortality, MI, or any unplanned TVR, were unaffected. Meta-regression indicated a significant relationship between prolonged total ischemic and reduced risk of MACE after deferred stenting (OR = 0.994, 95% CI: 0.990–0.998; p = 0.027; I2 residual 0.0%, adjusted R2 = 100.0%). Conclusions Although deferred stenting carried significantly lower risk of periprocedural composite events and abnormal flow in patients undergoing primary PCI for STEMI, such benefits had no impact on MACE, which did not differ significantly by timing of stent placement.
KW - Meta-analysis
KW - No reflow
KW - Outcomes
KW - Percutaneous coronary intervention
KW - ST-segment elevation myocardial infarction
UR - https://www.scopus.com/pages/publications/85008445045
U2 - 10.1016/j.ijcard.2016.12.071
DO - 10.1016/j.ijcard.2016.12.071
M3 - Article
C2 - 28057364
AN - SCOPUS:85008445045
SN - 0167-5273
VL - 230
SP - 509
EP - 517
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -